Disease Progression in Women With X-linked Adrenoleukodystrophy
Recruiting
Observational Study
X-linked Adrenoleukodystrophy
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
40 (estimated)
Sponsor
Minoryx Therapeutics, S.L. · Industry
Who this trial is looking for
This trial is looking for women aged 18 and older who have been diagnosed with X-linked Adrenoleukodystrophy (ALD). Participants will need to have annual follow-up visits that include MRI scans of the brain and spinal cord.
Are You a Good Fit for This Trial?
Must not be takingLeriglitazone
You may be able to join if
I am a woman aged 18 years or older.
I have been diagnosed with X-linked ALD.
I am willing to have annual follow-up visits.
I will provide written consent.
I am affiliated with the French social security system.
You may not be able to join if
I have a condition that could affect my participation in the study.
I have received treatment with leriglitazone.
I am currently pregnant or breastfeeding.
I am legally under guardianship or deprived of liberty.
I am participating in another clinical trial.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Observational, single-site prospective and minimally interventional study in women with X-linked adrenoleukodystrophy (ALD), conducted in France.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
1. Women aged 18 years old or older.
2. Diagnosis of X-linked ALD based on genetic testing, altered VLCFA levels, or family history.
3. Willing to undergo annual follow-up visits, including brain and spinal cord MRI scans.
4. Provision of written informed consent.
5. Affiliation…
Inclusion Criteria:
1. Women aged 18 years old or older.
2. Diagnosis of X-linked ALD based on genetic testing, altered VLCFA levels, or family history.
3. Willing to undergo annual follow-up visits, including brain and spinal cord MRI scans.
4. Provision of written informed consent.
5. Affiliation or beneficiary of a French social security system or of such a regime.
Exclusion Criteria:
1. Any condition that in the opinion of the investigator are likely to adversely affect the study participation, interfere with study compliance, or confound the study results.
2. Under treatment or previous treatment with leriglitazone.
3. Pregnant or lactating women.
4. Subjects benefiting from laws aimed at protecting vulnerable adults: subjects being deprived of liberty by judicial or administrative decision, subjects under guardianship.
5. Participation in an interventional clinical trial.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
